Christine Ocampo, Vice President, Finance at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 77,700 shares at $3.29 ($255K) on 2013-05-15, disclosed to the SEC on 2013-05-17.
Scheduled sale ($255k) by Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.28 | 57,700 | $189K | 74.2% |
| 2 | $3.29 | 20,000 | $66K | 25.8% |
| Total | $3.28 avg | 77,700 | $255K | 100% |
| Filing → |
| AVNR | SELL | 2014-10-24 | $25K | — | Filing → |
| AVNR | SELL | 2014-09-17 | $520K | — | Filing → |
| AVNR | SELL | 2014-08-28 | $13K | — | Filing → |